These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 33723519)
1. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19. Chouw A; Milanda T; Sartika CR; Kirana MN; Halim D; Faried A Regen Eng Transl Med; 2022; 8(1):43-54. PubMed ID: 33723519 [TBL] [Abstract][Full Text] [Related]
2. Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives. Mattoli S; Schmidt M Adv Ther; 2023 Jun; 40(6):2626-2692. PubMed ID: 37069355 [TBL] [Abstract][Full Text] [Related]
4. Clinical progress in MSC-based therapies for the management of severe COVID-19. Rossello-Gelabert M; Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM Cytokine Growth Factor Rev; 2022 Dec; 68():25-36. PubMed ID: 35843774 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19. Hou XY; Danzeng LM; Wu YL; Ma QH; Yu Z; Li MY; Li LS World J Stem Cells; 2024 Apr; 16(4):353-374. PubMed ID: 38690515 [TBL] [Abstract][Full Text] [Related]
6. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes. Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911 [TBL] [Abstract][Full Text] [Related]
7. Stem Cell Secretome Modulated by Arsenicum album 30C Ameliorates Lipopolysaccharide-induced Cytokine Storm in Blood Mononuclear Cells in vitro. Aphale P; Sanap A; Sharma D; Kharat A; Kheur S; Gawade C; Somasundaram I; Bhonde R Homeopathy; 2024 Aug; 113(3):132-141. PubMed ID: 38061387 [TBL] [Abstract][Full Text] [Related]
8. Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia. Putra A; Widyatmoko A; Ibrahim S; Amansyah F; Amansyah F; Berlian MA; Retnaningsih R; Pasongka Z; Sari FE; Rachmad B F1000Res; 2021; 10():228. PubMed ID: 35350705 [TBL] [Abstract][Full Text] [Related]
9. Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy. Russo E; Corrao S; Di Gaudio F; Alberti G; Caprnda M; Kubatka P; Kruzliak P; Miceli V; Conaldi PG; Borlongan CV; La Rocca G Cells; 2023 Jun; 12(12):. PubMed ID: 37371134 [TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19. Taufiq H; Shaik Fakiruddin K; Muzaffar U; Lim MN; Rusli S; Kamaluddin NR; Esa E; Abdullah S Ther Adv Respir Dis; 2023; 17():17534666231158276. PubMed ID: 37128999 [TBL] [Abstract][Full Text] [Related]
11. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs. Jamshidi E; Babajani A; Soltani P; Niknejad H Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases. Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S Inflamm Regen; 2020; 40():14. PubMed ID: 32582401 [TBL] [Abstract][Full Text] [Related]
13. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19. Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA Cells; 2022 Jul; 11(14):. PubMed ID: 35883618 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review. Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652 [TBL] [Abstract][Full Text] [Related]
15. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients. Al-Khawaga S; Abdelalim EM Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757 [TBL] [Abstract][Full Text] [Related]
16. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Can A; Coskun H Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878 [TBL] [Abstract][Full Text] [Related]
17. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System. Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia. Hezam K; Mo R; Wang C; Liu Y; Li Z Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol. Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123 [TBL] [Abstract][Full Text] [Related]
20. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment. Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]